177 related articles for article (PubMed ID: 20336772)
1. Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors.
Trojan J; Hammerstingl R; Engels K; Schneider AR; Zeuzem S; Dietrich CF
J Clin Ultrasound; 2010 Jun; 38(5):227-31. PubMed ID: 20336772
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound of histologically proven liver hemangiomas.
Dietrich CF; Mertens JC; Braden B; Schuessler G; Ott M; Ignee A
Hepatology; 2007 May; 45(5):1139-45. PubMed ID: 17464990
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
5. Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US.
Bartolotta TV; Taibbi A; Galia M; Lo Re G; La Grutta L; Grassi R; Midiri M
Eur J Radiol; 2007 Dec; 64(3):447-55. PubMed ID: 17433596
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
7. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced sonographic appearance of malignant fibrous histiocytoma in the sigmoid colon: a case report.
Wang YJ; Tang SS; Zhao Y
J Clin Ultrasound; 2012 Sep; 40(7):439-42. PubMed ID: 22886378
[TBL] [Abstract][Full Text] [Related]
9. Hepatic angiomyolipomas: ultrasonic characteristics of 25 patients from a single center.
Wang B; Ye Z; Chen Y; Zhao Q; Huang M; Chen F; Li Y; Jiang T
Ultrasound Med Biol; 2015 Feb; 41(2):393-400. PubMed ID: 25542497
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of hepatic tumors with contrast-enhanced ultrasound and digital grey-scale analysis].
Lemke AJ; Chopra SS; Hengst SA; Brinkmann MJ; Steinmüller T; Felix R
Rofo; 2004 Nov; 176(11):1607-16. PubMed ID: 15497079
[TBL] [Abstract][Full Text] [Related]
11. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.
Li R; Zhang X; Hua X; Cai P; Zhong H; Guo Y; Ding S; Yan X
Abdom Imaging; 2010 Dec; 35(6):676-82. PubMed ID: 20020286
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
[TBL] [Abstract][Full Text] [Related]
14. [Contrast ultrasonography: value in diagnosis and characterisation of hepatic tumors].
Aubé C; Lebigot J
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B63-70. PubMed ID: 12843939
[No Abstract] [Full Text] [Related]
15. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis of focal liver lesions in signal-enhanced ultrasound using BR 1, a second-generation ultrasound signal enhancer.
Peschl R; Werle A; Mathis G
Dig Dis; 2004; 22(1):73-80. PubMed ID: 15292698
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasound study of primary hepatic angiosarcoma: a pitfall of non-enhancement.
Wang L; Lv K; Chang XY; Xia Y; Yang ZY; Jiang YX; Dai Q; Tan L; Li JC
Eur J Radiol; 2012 Sep; 81(9):2054-9. PubMed ID: 21737220
[TBL] [Abstract][Full Text] [Related]
18. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
19. Software-based quantification of contrast-enhanced ultrasound in focal liver lesions--a feasibility study.
Goertz RS; Bernatik T; Strobel D; Hahn EG; Haendl T
Eur J Radiol; 2010 Aug; 75(2):e22-6. PubMed ID: 19962262
[TBL] [Abstract][Full Text] [Related]
20. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]